BOUTIQUE OF EXCELLENCE: OUR GÖDÖLLŐ PLANT IN HUNGARY
100 YEARS OF HISTORY AS A PROTAGONIST IN THE CARE OF PATIENTS
This year, our Gödöllő plant proudly celebrates its 100th anniversary. For a century, it has stood as a pillar of innovation and patient care in Hungary.
In 2008, Kedrion acquired the Gödöllő production facility, just 30 kilometers from Budapest, marking the beginning of our direct presence in Hungary. Over the years, the Gödöllő plant has played a key role within our global industrial network.
With a plasma fractionation capacity of 600,000 liters and a dedicated workforce of around 200 people, the Gödöllő plant specializes in the production of intermediates for our life-saving Immunoglobulins and Human Albumin.
In recent years, the Hungarian site has played a critical role in supporting drug research projects, such as the development of our new 10% Immunoglobulin which will be available to patients from next year in the United States.
As we celebrate this remarkable history, we also reaffirm our commitment to the Gödöllő plant, a center of excellence for us.
“What we’re honoring today is the 100th anniversary of a science-driven company, a century of history and dedication to health. As we look back on our collective achievements, I also want to reaffirm our commitment to this boutique of excellence we have here in Gödöllő. This site remains a key player in Kedrion’s mission to enhance and save patient lives worldwide.” – Ugo Di Francesco, CEO, stated.
“I remember those before us with gratitude for their courage and innovative approach; I am grateful for everything we are having now: our noble mission, a workplace for 200 people in Hungary as an integral part of Kedrion Biopharma, a solid global company, and a great city with excellent neighbours to work with.” – László Siadik, MD, commented.
